Sep 10, 2024 Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders We are pleased to announce three new UK DRI Emerging Leaders: Dr Maura Malpetti, Dr... Learn more Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders
Jan 01, 2024 Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
Search for keywords Condition ConditionAlzheimer's diseaseFrontotemporal dementiaHuntington's diseaseLewy body dementiaMild cognitive impairmentMotor neuron disease/ALSOther conditionsParkinson's diseaseVascular dementia Techniques TechniquesAdvanced microscopy & imagingAdvanced spectroscopyBioinformaticsBiophysical techniquesCRISPRDrug screeningElectrophysiologyEpigenomicsExperimental medicineFlow cytometryFluid biomarkersGenomicsHuman brain imagingLipidomicsMass spec-based proteomicsMetabolomicsMouse behaviourMouse in vivo imagingNext generation sequencingNon-mammalian animal modelsOptogeneticsRobotics & environmental sensingSingle cell / nucleus transcriptomicsSoftware developmentSpatial transcriptomicsStatistical modellingStem cells / iPSCsStructural biologyTranscranial brain stimulationViral-mediated expression Topic TopicAgeingBiomarkers & diagnosticsCare & Home technologyCell biology of neurons & gliaGeneticsImmune systemLifestyle & environmentMolecular mechanismsSleep & Circadian rhythmsSynapse & CircuitryTreatments & InterventionsVascular system Olivia Marshall Public Affairs Manager Learn more Olivia Marshall Dr Sarah Marzi Group Leader UK DRI at King's Investigating how epigenetics regulates biological mechanisms in health and disease Learn more Dr Sarah Marzi Dr Tom Massey Group Leader UK DRI at Cardiff Using recent genetic discoveries to develop new drug targets for Huntington's disease Learn more Dr Tom Massey Prof Paul Matthews Group Leader UK DRI at Imperial Exploring neuronal vulnerability and genetic risk variants in Alzheimer’s progression Learn more Prof Paul Matthews Dr Barry McColl Group Leader UK DRI at Edinburgh Investigating the role of microglia in neurodegenerative disease Learn more Dr Barry McColl Prof Will McEwan Group Leader UK DRI at Cambridge Deciphering the mechanisms of tau accumulation and exploring new methods for treatment of tauopathies Learn more Prof Will McEwan Dr Georgina Menzies UK DRI Co-investigator Cardiff University Lecturer, School of Biosciences, Cardiff University Learn more Dr Georgina Menzies Dr Veronique Miron Group Leader UK DRI at Edinburgh Using human brain tissue analysis and experimental modelling to understand how myelin changes with ageing and dementia Learn more Dr Veronique Miron Dr Jackie Mitchell UK DRI Co-investigator King's College London Lecturer in In Vivo Modelling of Neurodegeneration, King's College London Learn more Dr Jackie Mitchell Dr Sarah Mizielinska Group Leader UK DRI at King's Understanding the precise mechanisms of nucleocytoplasmic dysfunction in FTD and ALS Learn more Dr Sarah Mizielinska Dr Axel Montagne Group Leader UK DRI at Edinburgh Exploring the link between cerebrovascular and inflamm-ageing to neurodegeneration and dementia Learn more Dr Axel Montagne Prof Paul Morgan Interim Centre Director UK DRI at Cardiff Investigating exactly how key immune proteins contribute to Alzheimer's disease development Learn more Prof Paul Morgan Pagination First page First Previous page ‹ … Page 6 Page 7 Current page 8 Page 9 Page 10 … Next page › Last page Last
Dr Sarah Marzi Group Leader UK DRI at King's Investigating how epigenetics regulates biological mechanisms in health and disease Learn more Dr Sarah Marzi
Dr Tom Massey Group Leader UK DRI at Cardiff Using recent genetic discoveries to develop new drug targets for Huntington's disease Learn more Dr Tom Massey
Prof Paul Matthews Group Leader UK DRI at Imperial Exploring neuronal vulnerability and genetic risk variants in Alzheimer’s progression Learn more Prof Paul Matthews
Dr Barry McColl Group Leader UK DRI at Edinburgh Investigating the role of microglia in neurodegenerative disease Learn more Dr Barry McColl
Prof Will McEwan Group Leader UK DRI at Cambridge Deciphering the mechanisms of tau accumulation and exploring new methods for treatment of tauopathies Learn more Prof Will McEwan
Dr Georgina Menzies UK DRI Co-investigator Cardiff University Lecturer, School of Biosciences, Cardiff University Learn more Dr Georgina Menzies
Dr Veronique Miron Group Leader UK DRI at Edinburgh Using human brain tissue analysis and experimental modelling to understand how myelin changes with ageing and dementia Learn more Dr Veronique Miron
Dr Jackie Mitchell UK DRI Co-investigator King's College London Lecturer in In Vivo Modelling of Neurodegeneration, King's College London Learn more Dr Jackie Mitchell
Dr Sarah Mizielinska Group Leader UK DRI at King's Understanding the precise mechanisms of nucleocytoplasmic dysfunction in FTD and ALS Learn more Dr Sarah Mizielinska
Dr Axel Montagne Group Leader UK DRI at Edinburgh Exploring the link between cerebrovascular and inflamm-ageing to neurodegeneration and dementia Learn more Dr Axel Montagne
Prof Paul Morgan Interim Centre Director UK DRI at Cardiff Investigating exactly how key immune proteins contribute to Alzheimer's disease development Learn more Prof Paul Morgan
